Attorney General Camacho joins bipartisan coalition pushing FDA to examine progress in opioid fight

January 12, 2020- Tamuning, Guam- Attorney General Leevin Taitano Camacho has joined a broad coalition of 48 attorneys general in pushing federal regulators to examine recent progress in their fight against opioid abuse. The bipartisan coalition specifically seeks a progress report regarding recent steps taken by the U.S. Food and Drug Administration (FDA) to combat the opioid crisis, given the new authorities Congress granted the agency in 2018.

In their letter to FDA Commissioner Stephen Hahn, the attorneys general seek clarification of how the FDA is using and plans to use powers granted under the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act). Those provisions include safer opioid packaging and disposal features, research and issuance of new regulations on non-addictive alternatives to opioids and guidelines for opioid prescribing.

The attorneys general believe the FDA plays a critical role in ensuring both the safety and efficacy of opioids and encouraging non-addictive, non-opioid alternatives for treating pain.

Attorney General Camacho signed the West Virginia- and New Mexico-led letter with attorneys general of Alabama, Alaska, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Montana, Nebraska, Nevada, New  Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Utah, Vermont, U.S. Virgin Islands, Virginia, Washington, and Wisconsin.

Read a copy of the coalition’s letter here.